Study Characteristics.

3TC, lamivudine; ATV/r, ritonavir-boosted atazanavir; AZT, zidovudine; ABC, abacavir; d4T, stavudine; DTG, dolutegravir; EFV, efavirenz; FTC, emtricitabine; LPV/r, ritonavir-boosted lopinavir; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI/r, ritonavir-boosted protease inhibitor; RAL, raltegravir; TDF, tenofovir disoproxil fumarate.3TC，拉米夫定（lamivudine）；ATV/r，利托那韦增效阿扎那韦（ritonavir-boosted atazanavir）；AZT，齐多夫定（zidovudine）；ABC，阿巴卡韦（abacavir）；d4T，司他夫定（stavudine）；DTG，多替拉韦（dolutegravir）；EFV，依非韦伦（efavirenz）；FTC，恩曲他滨（emtricitabine）；LPV/r，利托那韦增效洛匹那韦（ritonavir-boosted lopinavir）；NRTI，核苷类逆转录酶抑制剂（nucleoside reverse transcriptase inhibitor）；NNRTI，非核苷类逆转录酶抑制剂（non-nucleoside reverse transcriptase inhibitor）；PI/r，利托那韦增效蛋白酶抑制剂（ritonavir-boosted protease inhibitor）；RAL，拉替拉韦（raltegravir）；TDF，富马酸替诺福韦二吡呋酯（tenofovir disoproxil fumarate）